1Drug discovery:our understanding and perspectivesCHEN Wei2217-22202The drugs in therapy of chronic idiopathic thrombocytopenic purpura:romiplostim and eltrombopagYAO Yuan-bing, WANG Ling, XIA Yue, JIN Gui-lan2221-2225,22393Pharmaceutical research and development investment in China:problems and contermeasuresSUN Yan, SUN Li-hua2226-22304A comparison of innovative drug research and development abilities between China and foreign countries based on an evaluation system of pharmaceutical technology innovationYAO Xue-fang, DING Jin-xi, SHAO Rong, CHENG Can2231-22395Analysis of the revision of Chinese Patent Law and its detailed regulation of implementation: main points and influences on pharmaceutical enterprisesZHANG Qing-kui2240-22436Bayesian mixed treatment comparisons and implementation using WinBUGSLIAO Wei-qi, CHEN Ping-yan2244-22487Common problems and status on drug registration application dossier (1) :regulatory informationFENG Yi, LIU Lu, XIAO Hui-lai, TIAN Heng-kang, CHENG Lu-rong2249-2250,22538Common problems and status on drug registration application dossier (2) : pharmaceutical study of chemical drugsLIU Lu, CHENG Lu-rong, XIAO Hui-lai, TIAN Heng-kang, FENG Yi2251-22539Common problems and status on drug registration application dossier (3) : pharmaceutical study of Traditional Chinese MedicinesTIAN Heng-kang, XIAO Hui-lai, CHENG Lu-rong, LIU Lu, FENG Yi2254-2254,226010Common problems and status on drug registration application dossier (4) : pharmacological and toxicological studiesCHENG Lu-rong, XIAO Hui-lai, TIAN Heng-kang, LIU Lu, FENG Yi2255-225711Common problems and status on drug registration application dossier (5) :bioavailability studyXIAO Hui-lai, CHENG Lu-rong, TIAN Heng-kang, LIU Lu, FENG Yi2258-226012Basic principles for nonclinical safety evaluation of the novel drugPENG Jian2261-226613Method and strategy research on reevaluation of traditional Chinese drugYANG Ming, WU Zhen-feng, WANG Fang, ZHENG Qin, YUE Peng-fei, HU Peng-yi, SONG Min-xian2267-227014Guidelines and recent developments of toxicological assessment of impurities in pharmaceutical productsZHU Qing-fen, LI Tao, GUO Ming, LI Jun2271-227615Development of novel anticancer drugsZHANG Wan-nian, MIAO Zhen-yuan2277-2284,228916Research progress in small molecule vascular disrupting agentsFENG Teng, GENG Mei-yu, LI Jing2285-228917Progress in the international development of new anti-hypertensive medicinesDU Hai-zhou, ZHANG Jian-ping, L(U) Ting, LIU Gui-ling, WANG Tian-jin, LIU Na, LIU Wei2290-2297,230218Advances in the research of drug toxicologyZHANG Xiao-fang, YUAN Bo-jun, LU Guo-cai, ZONG Ying2298-230219Efficacy of nadroparin calcium in diabetic patients with lower extremity atherosclerotic disease(Fontaine stage Ⅱ)JIANG Tao, WEN Zhen, SONG Xiu-xia, YAO Xiao-ai, KANG kai, LU Gui-yang2303-230720Effects of tramadol and tropisetron on shiver in patients undergoing combined spinal-epidural anesthesiaKONG Xue, CHEN Xiao-guang, GAO Yun-xia2308-2311 